The phrase "a plb" is not correct or usable in written English as it lacks context and clarity.
It could potentially be used in a specific context where "plb" is defined, such as an acronym or abbreviation, but without that context, it is unclear.
Example: "I need to order a plb for the project, but I can't remember what it stands for."
Alternatives: "a placeholder" or "a part label".
However, the Groundhog SATA controller, which although allows for a lot of design flexibility to interface directly with its SATA command layer via custom hardware, is not capable of being connected directly to a PLB interface without significant design additions.
Note that despite having been introduced into Matrigel co-mingled, cells aggregate by type with mixed-cell colonies characteristically having a pLB core surrounded by pLUM.
Hv1 expression might be impaired in PLB-985 X CGD cells for the following reasons: a) PLB-985 X CGD clone has a general differentiation problem, b) PLB-985 X CGD is a clone in which Hv1 expression is diminished in a Nox2 independent manner or c) normal Nox2 expression is required for normal Hv1 expression.
94% of the overall patients were willing to undergo a repeat PLB if clinically indicated; there was no significant difference between the two groups (94% vs 94%, NS) (Table 2).> There were five patients in the pethidine group and four patients in the placebo group with vasovagal reactions.
The panel consisted of a geriatrician (TLB), orthopaedic surgeon (ZJB), an anaesthetist (PLB) and general physician (JA).
A single touch stimulus produced a maintained depolarization of PlB and an increase in tonic firing.
In addition, our results are supported by studies using rodent diabetic models that have reported an up-regulation of SERCA2a, a down-regulation of PLB and an improved contractile function following insulin treatment [ 19, 41].
Additionally, in both models, AF was associated with a significant decrease in the phosphorylation of phospholamban (PLB), a key regulator of SERCA.
To develop a matrix-type, controlled-release tablet formulation of pelubiprofen (PLB), a recently developed non-steroidal anti-inflammatory drug, polymeric excipients including hypromellose, hydroxypropylcellulose, Eudragit® RS PO, and Kollidon® SR were screened.
Immunoprecipitations using an anti-PLB antibody pull down a significant amount of PDE activity from human heart extracts, indicating that PDEs are localized to this complex as well (Fig. 4b).
The protein A-agarose beads were washed repeatedly with PLB followed by a second round of washes with PLB containing 1 M urea.
